ProZyme: Agilent Technologies Completes Acquisition of ProZyme
Agilent Technologies Inc. NYSEA today announced that it has completed the acquisition of ProZyme Inc. a leading provider of glycan reagents kits and standards. This acquisition expands Agilents portfolio of biopharma consumables. ...
Read full article »
ProZyme is a medical device company that develops and provides glycan analysis reagents, kits and standards for biopharma and academic institutions.
Read more